The 20 Best Brain Tumor Doctors Near Me

David Cachia is a Neurologist and an Oncologist practicing medicine in Marlborough, Massachusetts. Dr. Cachia is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Ependymoma. Dr. Cachia is board certified in Neurology and Neuro-Oncology. Dr. Cachia is currently accepting new patients.

John De Groot is a Neurologist practicing medicine in San Francisco, California. Dr. De Groot is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Tobias Walbert is a Neurologist practicing medicine in Detroit, Michigan. Dr. Walbert is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Brain Tumor, Glioblastoma, and Astrocytoma. Dr. Walbert is currently accepting new patients.

Andrew Sloan is a Neurosurgery provider practicing medicine in Centerville, Ohio. Dr. Sloan is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Sloan is currently accepting new patients.

Marta Penas-Prado is a Neurologist practicing medicine in Cary, North Carolina. Dr. Penas-Prado is rated as an Elite provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Brain Tumor, and Glioma.

Shiao-pei Weathers is a Neurologist practicing medicine in Houston, Texas. She has been practicing medicine for over 17 years. Dr. Weathers is rated as an Elite provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Brain Tumor, and Awake Craniotomy.

David Ashley is a Hematologist and an Oncologist practicing medicine in Durham, North Carolina. Dr. Ashley is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. Dr. Ashley is currently accepting new patients.

Patrick Wen is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Wen is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Wen is board certified in Neurology and Neuro-Oncology. Dr. Wen is currently accepting new patients.

Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is rated as an Elite provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy. Dr. Blakeley is board certified in American Board Of Psychiatry And Neurology. Dr. Blakeley is currently accepting new patients.

David Peereboom is an Oncologist and a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. Dr. Peereboom is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioblastoma, Glioma, Astrocytoma, and Bone Marrow Aspiration. Dr. Peereboom is board certified in United Council For Neurological Subspecialties, 2008. Dr. Peereboom is currently accepting new patients.

Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine. Dr. Holdhoff is currently accepting new patients.

Roger Stupp is a Hematologist Oncology specialist and a Neurologist practicing medicine in Chicago, Illinois. Dr. Stupp is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Stupp is currently accepting new patients.

Chetan Bettegowda is the director of the Johns Hopkins Department of Neurosurgery. He offers comprehensive treatments for adult patients with benign and malignant brain tumors, specializing in the treatment of patients with primary brain tumors such as gliomas, meningiomas and pituitary tumors. He performs both open surgery and stereotactic radiosurgery for patients with metastatic tumors to the brain, and also provides stereotactic radiosurgery for other neurological disorders, including spinal tumors, trigeminal neuralgia and skull-base tumors. Dr. Bettegowda is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Astrocytoma, Glioblastoma, Rhizotomy, and Microvascular Decompression. Dr. Bettegowda is board certified in American Board Of Neurological Surgery. Dr. Bettegowda is currently accepting new patients.

As a cancer doctor, I strive to provide the kind of care that I would want for my own family. My aim is to use my expertise, knowledge, and understanding of the human condition to empower patients. While scientific knowledge and approaches are at the core of what I do, I find it important to aim to integrate the human context into what my team and I offer patients and their families. Having lived, trained, and worked in different countries, including Australia, the United Kingdom, the Netherlands, and the United States, I have developed unique insights into the practice of medicine and cancer care around the world. These experiences have given me a broader perspective and helped inform my approach to individualized patient care. I see my ability to help patients as a privilege, and I do get enormous pleasure from being able to help. When not working, I am an avid reader and enjoy running, cycling, and spending time with my family. Dr. Khasraw is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Khasraw is currently accepting new patients.

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is rated as an Elite provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy. Dr. Sahebjam is board certified in American Board Of Internal Medicine. Dr. Sahebjam is currently accepting new patients.

Karen Fink, MD, PhD, is the Medical Director of Clinical Neuro-Oncology Research at Baylor University Medical Center.  Dr. Fink leads our neuro-oncology team, heading the multi-disciplinary Baylor Scott and White Sammons Cancer Center brain tumor board and multiple clinical trials for patients with brain tumors. She has a long history of involvement in advanced clinical trials in collaboration with industry groups and with prominent neuro-oncology programs nationwide. Dr. Fink received her undergraduate degree in biochemistry from Washington University in St. Louis, Missouri. She then completed her MD and PhD at the Mayo Clinic in Rochester, Minnesota, where she investigated early cellular activation of cancer-causing genes in response to growth signals. Her Neurology residency and Neuro-oncology fellowship were accomplished at UT Southwestern Medical Center in Dallas. She stayed there after completing her training, becoming the Director of Clinical Neuro-Oncology. She moved to Baylor University Medical Center to found Neuro-Oncology Associates in 2006. At Baylor Scott & White, she continued to offer clinical trials as an investigator in the North American Brain Tumor Consortium, and later, the Brain Tumor trials Collaborative spearheaded at the National Institute of Health. She still works with pharmaceutical and device companies to offer advanced treatments for patients with brain tumors. Dr. Fink has participated in over 50 neuro-oncology clinical trials, been an author on over 50 peer reviewed publications, and over 80 abstracts covering various aspects of Neuro-Oncology research. She mentors Neurology Residents, Oncology fellows and medical students, instilling knowledge regarding the management of primary brain tumor patients and providing an example of compassionate and up-to-date clinical care. Dr. Fink has formally served as a member of the Corporate Compliance Committee and the Multidisciplinary Cancer Committee at Baylor Scott and White. She is a member of the Society for Neuro-Oncology and the American Society of Clinical Oncology. Dr. Fink specializes in the treatment of tumors in the brain, central nervous system, and peripheral nervous system. She collaborates with Neuro-Oncology clinicians and their medical teams in north and central Texas, and with Neurosurgeons, Radiation Oncologists, Medical Oncologists, Neuro-Radiologists and Palliative Care clinicians across the region to coordinate complete care for patients and their loved ones who are dealing with a brain tumor. Dr. Fink has been named one of Texas Monthly's Texas Super Doctors for over 10 years earning her a place on Texas Monthly's Hall of Fame list. Read more about Dr. Fink’s research publications on PubMed.gov. Dr. Fink is rated as an Elite provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Fink is board certified in Neurology- American Board Of Psychiatry And Neurology/Neurology and Neurology- American Board Of Psychiatry And Neurology. Dr. Fink is currently accepting new patients.

David Reardon is a Hematologist Oncology specialist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Reardon is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Reardon is currently accepting new patients.

Howard Colman is a Neurologist practicing medicine in Salt Lake City, Utah. Dr. Colman is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Colman is board certified in American Board Of Psychiatry And Neurology and American Board Of Surgery. Dr. Colman is currently accepting new patients.

Santosh Kesari is a Neurologist practicing medicine in Santa Monica, California. Dr. Kesari is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Kesari is currently accepting new patients.

Priya Kumthekar is a Hematologist Oncology specialist and a Neurologist practicing medicine in Chicago, Illinois. Dr. Kumthekar is rated as an Elite provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Kumthekar is board certified in American Board Of Psychiatry And Neurology - Neurology (Certified). Dr. Kumthekar is currently accepting new patients.